Experiense of treatment with a growth hormone receptor antagonist in patients with hereditary form of acromegaly: clinical cases

Experiense of treatment with a growth hormone receptor antagonist in patients with hereditary form of acromegaly: clinical cases

Acromegaly is a severe neuroendocrine disease caused by chronic excessive production of somatotropic hormone (STH), characterized by specific changes in appearance, metabolic disorders. In 95% of cases, the cause of pathology is STH-producing pituitary adenomas. The priority method of treatment for...

Full description

Bibliographic Details
Main Authors: L. K. Dzeranova, A. V. Dorovskikh, E. A. Pigarova, E. G. Przhiyalkovskaya, A. S. Shutova, M. I. Yevloyeva, A. Yu. Grigoriev, V. N. Azizyan, O. V. Ivashchenko
Format: Article
Language:English
Published: Endocrinology Research Centre 2022-09-01
Series:Ожирение и метаболизм
Subjects:
pituitary neoplasms
somatotropinoma
acromegaly
somatostatin analogues
octreotide
familial isolated pituitary adenomas
mccune-albright syndrome
growth hormone receptor antagonist
pegvisomant
Online Access:https://www.omet-endojournals.ru/jour/article/view/12831

Internet

https://www.omet-endojournals.ru/jour/article/view/12831

Similar Items